Contrast Media/Contrast Agents Market
Contrast Media/Contrast Agents Market - Global Industry Assessment & Forecast
#
Pages:
146
2022
Mar - 2022
VMR-1424
Segments Covered
By
Type Iodinated Contrast Media, Gadolinium- Based Contrast Media, Microbubble Contrast Media, Barium- Based Contrast Media
-
By
Modality X- Ray/ CT, MRI, Ultrasound
-
By
Administration Intravascular Route, Oral Route, Rectal Route, Others
-
By
Indication Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders
-
By
Application Radiology, Interventional Radiology, Interventional Cardiology
-
By
End User Hospital, Clinics, & Ambulatory Surgery Centers, Diagnostic Imaging Centers
-
By
Regions North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 4889.79 Million |
 Revenue 2030:
|
USD 6389.31 Million |
 Revenue CAGR
(2023 - 2030): |
3.40% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Contrast Media/Contrast Agents Market by Type by Modality by Administration by Indication by Application by End User by Regions - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
The later stage covers data validation and collection from primary research. The information gained/procured from the secondary data sources is validated through extensive primary interviews with industry experts across the Contrast Media/Contrast Agents supply chain. The primary research is also conducted to identify key players in the market and to gather and validate already procured information pertaining to their market-specific financial information. Moreover, primary research is used to gain/validate information about:
- Contrast Media/Contrast Agents market size at regional and country level
- Key industry players and their market share and Contrast Media/Contrast Agents market-specific sales/revenue
- Understanding of the Contrast Media/Contrast Agents supply chain and overall ecosystem
Data Triangulation and Market Size Estimations
After arriving at the global market numbers, top-down and bottom-up approaches are used to estimate, validate and finalize the market size of the Contrast Media/Contrast Agents market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. During the data triangulation process, the data was analyzed by employing various data models and statistical techniques to arrive at exact statistics and market size for each segment/sub-segment of the market. The data is analyzed and triangulated by considering all the key market impacting factors from both supply and demand side of Contrast Media/Contrast Agents market.
FAQ
Frequently Asked Question
What is the global demand for Contrast Media/Contrast Agents in terms of revenue?
-
The global Contrast Media/Contrast Agents valued at USD 4889.79 Million in 2022 and is expected to reach USD 6389.31 Million in 2030 growing at a CAGR of 3.40%.
Which are the prominent players in the market?
-
The prominent players in the market are GE Healthcare (US), Bracco Imaging SPA (Italy), Bayer AG (Germany), Guerbet (France), Lantheus Medical Imaging Inc. (US), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals Ltd. (India), SANOCHEMIA Pharmazeutika GmbH (Austria), Taejoon Pharm (South Korea), Jodas Expoim (India), Nano Therapeutics Pvt. Ltd. (India), Kiran X-ray (India), iMax Diagnostic Imaging Limited (Ireland), YZJ Group (China), Livealth Biopharma Pvt. Ltd. (India), Trivitron Healthcare Pvt. Ltd. (India), Novalek Pharmaceuticals Pvt. Ltd. (India), Unispire Biopharma Private Limited (India), Acro Lifesciences (I) Pvt. Ltd. (India), Congruent Pharmachem Private Limited (India), Stanex Drugs & Chemical Pvt. Ltd. (India), Beijing Beilu Pharmaceutical Co., Ltd. (China), Rege Imaging & Cine Films Private Limited (India), K DIAM EXIM (India), Onko Ýlaç San. ve Tic. A.Þ. (Turkey), and Subhra Pharma Pvt. Ltd. (India).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 3.40% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Contrast Media/Contrast Agents include
- Rising prevalence of chronic diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Contrast Media/Contrast Agents in 2022.
